R&D News | pharmaphorum

News

AlphaFold 3 takes structure predictions well beyond proteins

The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not only of proteins, but “all of life’s molecules”,

News

Report warns economic instability has hit UK drug discovery

A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on

News

New metric predicts burden of participating in trials

After patients enrol in clinical trials, regular assessments and testing – often requiring clinic visits – can become onerous and reduce the chances they will stick with t

News

Regeneron gene therapy restores hearing in deaf child

Regeneron’s gene therapy for otoferlin-related hearing loss – a genetic cause of deafness – has restored hearing to normal levels in one profoundly deaf child within just

News

RNA blood test may predict antidepressant response

Selective serotonin reuptake inhibitors (SSRIs) are the first-line drug therapy of choice for most people suffering from depression but often fail to work effectively.

News

Zenas’ $200m round heads big clutch of bio financings

Our round-up of recent biotech financings is headed by a sizeable $200 million third round for Zenas BioPharma, with Cellectis, Reunion Neuroscience, Karius, Context Thera

AlphaFold 3 takes structure predictions well beyond proteins

Report warns economic instability has hit UK drug discovery

New metric predicts burden of participating in trials

Regeneron gene therapy restores hearing in deaf child

RNA blood test may predict antidepressant response

Zenas’ $200m round heads big clutch of bio financings

Bayer hits "turning point" in recovery plan, says CEO

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks